KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Long-Term Debt Repayments (2018)

Historic Long-Term Debt Repayments for Arbutus Biopharma (ABUS) over the last 1 years, with Q1 2018 value amounting to $12.0 million.

  • Arbutus Biopharma's Long-Term Debt Repayments changed N/A to $12.0 million in Q1 2018 from the same period last year, while for Dec 2018 it was $12.0 million, marking a year-over-year change of. This contributed to the annual value of $12.0 million for FY2018, which is N/A changed from last year.
  • Arbutus Biopharma's Long-Term Debt Repayments amounted to $12.0 million in Q1 2018.
  • Over the past 5 years, Arbutus Biopharma's Long-Term Debt Repayments peaked at $12.0 million during Q1 2018, and registered a low of $12.0 million during Q1 2018.